Zydus Cadila gets USFDA nod to market acne drug

| | New Delhi
  • 0

Zydus Cadila gets USFDA nod to market acne drug

Sunday, 30 December 2018 | PTI | New Delhi

Drug firm Zydus Cadila Saturday said it has received final nod from the US health regulator to market Clindamycin Phosphate and Benzoyl Peroxide gel, used in the treatment of acne.

This combination medication is used to treat a certain type of acne (inflammatory acne vulgaris), the company said in a BSE filing. It also helps to decrease the number of acne pimples.

“Zydus Cadila has received the final approval from the USFDA to market Clindamycin Phosphate and Benzoyl Peroxide Gel, (US RLD —DUAC® Gel), 1.2 per cent/5 per cent.

“It will be manufactured at the group’s Topical manufacturing facility at Ahmedabad,” it added.

Clindamycin is an antibiotic that stops the growth of acne-causing bacteria. Benzoyl peroxide can also stop the growth of bacteria as well as reduce oil production in the skin, it further said.

State Editions

51-year old man run over by speeding car

18 February 2019 | Staff Reporter | Bhopal

20-year-old arrested for sexually assaulting toddler

18 February 2019 | Staff Reporter | Bhopal

Three arrested for molesting 25-yr-old

18 February 2019 | Staff Reporter | Bhopal

41-year-old man dies in road mishap near Ganesh Mandir

18 February 2019 | Staff Reporter | Bhopal

Labourers at industrial area deprived of rights

18 February 2019 | Vikas Tyagi | Bhopal

Seminar on Gender mainstreaming in water resources mgmt ends

18 February 2019 | Staff Reporter | Bhopal

Sunday Edition

27 more hotels to shut in Karol Bagh in Delhi

17 February 2019 | PTI | Sunday Pioneer

Tech Mahindra board to meet on Feb 21

17 February 2019 | PTI | Sunday Pioneer

HCSL begins construction of new yard

17 February 2019 | PTI | Sunday Pioneer

Apollo Hospital offers to treat free injured CRPF troopers

17 February 2019 | PNS | Sunday Pioneer